Physician profile
Ashley Gardner
NPI 1467902825
$449.60
in general payments reported to CMS, 2019-2025
13 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $146 · 2024: $103 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $91.35 | 2023 | Veozah |
| Organon LLC | $75.14 | 2024-2025 | Nexplanon, Nuvaring |
| Exact Sciences Corporation | $49.95 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $47.81 | 2025 | Airsupra |
| Glaxosmithkline, LLC. | $28.99 | 2025 | Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $24.43 | 2023 | Gvoke Hypopen |
| Ascensia Diabetes Care US INC. | $22.19 | 2025 | |
| Lilly USA, LLC | $21.44 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $20.58 | 2024 | Spravato |
| Lundbeck LLC | $20.01 | 2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $19.46 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $14.26 | 2025 | |
| Pfizer INC. | $13.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.